Palbociclib Plus Fulvestrant as First-Line Therapy for Patients with Locally Advanced, Inoperable or Metastatic HR+/HER2-Breast Cancer in Germany: Interim Results of the Inge-B Phase 2 Study
ONCOLOGY RESEARCH AND TREATMENT（2020）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要